1 mg semaglutide equivalent tirzepatide vs 2026: 22% vs 15% Weight Loss Guide switching from tirzepatide to semaglutide

Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74

IGF-1 LR3 is a recombinant long-acting insulin-like growth factor-1 analog supplied for laboratory research use only

Regular check-ins help us track your progress, adjust your dosage as necessary, and make sure youre achieving your weight and body composition goals